Clinical Trial Update: A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized trial assessing letrozole and hCG therapy for male hypogonadism induced by anabolic steroid use; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Hypogonadotropic Hypogonadism

Drugs mentioned

• Human chorionic gonadotropin (human chorionic gonadotropin)
• Letrozole (letrozole)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Hypogonadism, Hypogonadism, Male | Phase 4 | Status: TERMINATED